Impact of atrial fibrillation and anticoagulation on the risk of death, thromboembolic disease and bleeding in patients with COVID-19: the ACO-VID Registry-Reference-Cited by-同舟云学术

Impact of atrial fibrillation and anticoagulation on the risk of death, thromboembolic disease and bleeding in patients with COVID-19: the ACO-VID Registry

Published:2023-05-15 Issue:6 Volume:39 Page:811-817
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Cerezo Manchado Juan José¹,Iturbe Hernández Teodoro¹,Martínez Pacheco María del Carmen²,Gil Ortega Ignacio³,Campoy Desirée⁴,Canals Pernas Tania⁵,Martínez Serra Laia⁶,Flores Aparco Katia Jessica⁷,Velásquez Escandón César Andrés⁸,Martínez Francés Antonio¹,Olivera Pável⁴

Affiliation:

1. Department of Hematology, Hospital Clínico Universitario Santa Lucía, Cartagena, Spain

2. Department of Teaching and Research, Hospital Clínico Universitario Santa Lucía, Cartagena, Spain

3. Department of Cardiology, Hospital Clínico Universitario Santa Lucía, Cartagena, Spain

4. Thrombosis and Hemostasis Unit, Department of Hematology, Valld’Hebron University Hospital, Barcelona, Spain

5. Departament of Hematology, Hospital Universitario Sant Joan de Reus, Reus, Spain

6. Department of Hematology, University Hospital Sant Joan de Reus, Tarragona, Spain

7. Department of Hematology, General University Hospital of Catalonia, Barcelona, Spain

8. Department of Hematology, Fundació Sanitaria Mollet, Barcelona, Spain

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2023.2204009

Reference45 articles.

1. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?

2. World Health Organization. Coronavirus disease 2019 (COVID-19) situation report-51. 2020. Available from: https://apps.who.int/iris/handle/10665/331475

3. Clinical Characteristics of Coronavirus Disease 2019 in China

4. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of New Onset Atrial Fibrillation in Hospitalized Patients with COVID-19. Results of the “ACO-VID” Registry;Clinical and Applied Thrombosis/Hemostasis;2023-01